ClearPoint Neuro, Inc. (CLPT) vs Sanara MedTech Inc. (SMTI)
A side-by-side comparison of ClearPoint Neuro, Inc. and Sanara MedTech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLPT
ClearPoint Neuro, Inc.
$11.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SMTI
Sanara MedTech Inc.
$35.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CLPT vs SMTI
growth of $100 · dividends reinvested · last 10yCLPT +88.9% (+6.6%/yr)SMTI +775.0% (+24.2%/yr)SMTI compounded faster over this window
CLPT SMTI
CLPT vs SMTI: by the numbers
- •CLPT is the larger company ($330M vs $322M market cap).
- •Both run net losses; SMTI's is the smaller (-29.15% vs -81.76% net margin).
- •SMTI grew revenue faster over the past five years (40.06% vs 23.57% CAGR).
Metrics side by side
Valuation
| Metric | CLPT | SMTI |
|---|---|---|
| Forward P/E | N/A | 184.21 |
| P/S ratio | 7.81 | 2.93 |
| P/B ratio | 30.64 | 40.51 |
| EV / EBITDA | N/A | 27.80 |
| FCF yield | N/A | 1.40% |
Profitability
| Metric | CLPT | SMTI |
|---|---|---|
| Gross margin | 62.61% | 91.33% |
| Operating margin | -65.36% | 9.36% |
| Net margin | -81.76% | -29.15% |
| ROE | -320.77% | -403.03% |
| ROIC | -40.51% | 18.15% |
Growth (annualized)
| Metric | CLPT | SMTI |
|---|---|---|
| Revenue CAGR (5Y) | 23.57% | 40.06% |
| Total return CAGR (5Y) | -7.65% | 0.35% |
Frequently asked
- Which has grown faster, CLPT or SMTI?
- Over the past five years, SMTI grew revenue faster — CLPT at a 23.57% CAGR versus SMTI at 40.06%.
- How have CLPT and SMTI total returns compared?
- Over the past 10 years, CLPT delivered 6.57% and SMTI delivered 24.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ClearPoint Neuro ROESanara MedTech ROEClearPoint Neuro operating marginSanara MedTech operating marginClearPoint Neuro revenue growthSanara MedTech revenue growthClearPoint Neuro free cash flowSanara MedTech free cash flow
ClearPoint Neuro & Sanara MedTech appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.